Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular risk

Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular risk

Henry Covelli,1 Bonavuth Pek,2 Isabelle Schenkenberger,3 Catherine Scott-Wilson,4 Amanda Emmett,5 Courtney Crim4 1Kootenai Health, Coeur d’Alene, ID, USA; 2Clinique de Pneumologie et de Sommeil de Lanaudière, Quebec, Canada; 3Klinische Forschung, Berlin, Germany; 4GlaxoSmithKli...

Full description

Bibliographic Details
Main Authors: Covelli H, Pek B, Schenkenberger I, Scott-Wilson C, Emmett A, Crim C
Format: Article
Language:English
Published: Dove Medical Press 2015-12-01
Series:International Journal of COPD
Subjects:
fluticasone furoate/vilanterol
tiotropium
COPD
cardiovascular disease
ICS/LABA
Online Access:https://www.dovepress.com/efficacy-and-safety-of-fluticasone-furoatevilanterol-or-tiotropium-in--peer-reviewed-article-COPD

Internet

https://www.dovepress.com/efficacy-and-safety-of-fluticasone-furoatevilanterol-or-tiotropium-in--peer-reviewed-article-COPD

Similar Items